Standigm: Carl Foster, chief business officer
Artificial intelligence drug discovery company Standigm has appointed Carl Foster chief business officer. He will be responsible for expanding strategic partnerships for novel drug target discoveries and first-in-class lead candidate identifications.
"Carl has established a reputation for increasing company value. He has significant experience building and growing biotech companies, like Standigm, through creative deal-making," said Jinhan Kim, CEO of Standigm. "We're confident Carl can help us meet our aggressive goals."